San Jose, California (PRWEB) January 08, 2014
Follow us on LinkedIn – Gene expression refers to the process of unlocking the genetic code contained in the DNA. Understanding the functioning of genes remains critical towards identifying underlying causes of disease progression. Market for gene expression reagents has been benefiting from developments in biomedical gene expression profiling. As special chemicals developed for use in gene expression studies, gene expression reagents are currently witnessing strong demand in sync with the rise in gene expression tests. Growth in the market is also expected to benefit from the growing use of gene expression tests in diagnosis of thyroid cancer, colon cancer, multiple myeloma, uveal melanoma, and cardiovascular risk assessment.
The trend report titled “Gene Expression Reagents” announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the technology, its evolution, applications, future prospects, player market shares and corporate initiatives of key companies worldwide. The report also provides coverage on companies such as Affymetrix Inc., Agilent Technologies Inc., Epicentre® Biotechnologies, Eurogentec SA, Illumina Inc., Life Technologies Corporation, Mirus Bio LLC, Origene Technologies Inc., Roche Diagnostics, Sigma-Aldrich Co. LLC, and Thermo Fisher Scientific Inc., among others.
For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=146092.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 peopl
Copyright©2012 Vocus, Inc.
All rights reserved